| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/17/2013 | CN102174414B Application of new morchella costata M8-13 liquid fermentation substance in development of health-care products and medicaments |
| 07/17/2013 | CN102159215B Treating various disorders using TrkB agonists |
| 07/17/2013 | CN102120781B Preparation and application of novel oral insulin nanoparticles |
| 07/17/2013 | CN102099047B Composition for controlling increase in blood glucose |
| 07/17/2013 | CN102076347B Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 07/17/2013 | CN102058679B Medicine or health-care food composition for treating atherosclerosis |
| 07/17/2013 | CN101928329B Tripeptide boric acid (ester) compound and preparation method and application thereof |
| 07/17/2013 | CN101914150B Polypeptide and use thereof in medicament preparation |
| 07/17/2013 | CN101883575B Guava extract |
| 07/17/2013 | CN101744978B Drug composition for preventing and curing diabetes mellitus |
| 07/17/2013 | CN101641339B Compounds for the prevention and treatment of cardiovascular diseases |
| 07/17/2013 | CN101528695B Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 07/17/2013 | CN101528225B 2-aminobenzoxazole carboxamides as 5HT3 modulators |
| 07/17/2013 | CN101479008B Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower HDL-C and lower cholesterol |
| 07/17/2013 | CN101454310B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/17/2013 | CN101412744B Anti-angiogenic compositions and methods of use thereof |
| 07/17/2013 | CN101379086B Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 07/17/2013 | CN101378667B High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
| 07/17/2013 | CN101312661B Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
| 07/17/2013 | CN101312660B High-potency sweetener for weight management and compositions sweetened therewith |
| 07/17/2013 | CN101212979B 内脏脂肪蓄积抑制剂 Visceral fat accumulation inhibitor |
| 07/16/2013 | US8487003 Treatment of cancer by administration of perfluorooctanoic acid |
| 07/16/2013 | US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486937 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof |
| 07/16/2013 | US8486890 Amylin derivatives |
| 07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 07/16/2013 | US8486462 Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 07/16/2013 | US8486442 External patch containing estrogen and/or progestogen |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | CA2697167C Benzimidazole derivatives used as fxr agonists |
| 07/16/2013 | CA2673615C Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 07/16/2013 | CA2650627C Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2013 | CA2620026C Method for production of single- and multi-layer microcapsules |
| 07/16/2013 | CA2604584C Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder |
| 07/16/2013 | CA2581485C Methods and compositions for treating hyperglycemic, hyperlipidemic, or hyperinsulinemic disorders |
| 07/16/2013 | CA2534094C Glycosidase inhibitors and methods of synthesizing same |
| 07/16/2013 | CA2486106C Compounds and methods for inhibiting selectin-mediated function |
| 07/16/2013 | CA2464656C Spray drying methods and compositions thereof |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2384948C Therapies for chronic renal failure using one or more integrin antagonists |
| 07/16/2013 | CA2330231C Composition and method for modulating dendritic cell-t cell interaction |
| 07/11/2013 | WO2013103981A1 Compositions and methods of use of fndc5 polypeptides |
| 07/11/2013 | WO2013103936A1 Method of treating pain by administration of nerve growth factor |
| 07/11/2013 | WO2013103919A2 Compositions and methods for treating metabolic disorders |
| 07/11/2013 | WO2013103384A1 Biguanide compositions and methods of treating metabolic disorders |
| 07/11/2013 | WO2013103150A1 Acid adduct salt of substituted pyridine compound |
| 07/11/2013 | WO2013102899A1 Methods and compositions for treating diabetes |
| 07/11/2013 | WO2013102626A1 3-[4-(phenylaminooxalylamino)phenyl]hex-4-ynoic acids, process for preparation thereof and use thereof as a medicament |
| 07/11/2013 | WO2013065015A3 Butea monosperma and curcuma longa extracts for the prevention and treatment diabetic retinopathy and cataract |
| 07/11/2013 | WO2013052647A3 Formulations and uses of retinoic acid receptor selective agonists |
| 07/11/2013 | WO2013024358A3 Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (cetp) inhibitors |
| 07/11/2013 | US20130177647 Methods for manipulating satiety |
| 07/11/2013 | US20130177619 Vitamin powder composition and method of making |
| 07/11/2013 | CA2860669A1 Compositions and methods for treating metabolic disorders |
| 07/10/2013 | EP2612922A1 Eggshell membrane solubilization method using enzymes |
| 07/10/2013 | EP2612914A1 Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient |
| 07/10/2013 | EP2612703A2 Particulate materials |
| 07/10/2013 | EP2612678A1 Screening method for antidiabetic agent using newly identified insulin secretion regulation factor |
| 07/10/2013 | EP2612677A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 07/10/2013 | EP2612669A2 Use of the fetal reprogramming of a ppar agonist |
| 07/10/2013 | EP2612561A1 High protein liquid enteral nutritional composition |
| 07/10/2013 | EP2611919A2 Kinases as targets for anti-diabetic therapy |
| 07/10/2013 | EP2611827A1 Recombinant t-cell receptor ligands with covalently bound peptides |
| 07/10/2013 | EP2611810A1 Substituted tetrahydropyrrolopyrazine derivatives |
| 07/10/2013 | EP2611782A1 Salts of lorcaserin with optically active acids |
| 07/10/2013 | EP2611781A1 Fast-dissolve dosage forms of 5-ht2c agonists |
| 07/10/2013 | EP2611776A2 Production method of intermediate compound for synthesizing medicament |
| 07/10/2013 | EP2611462A2 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 07/10/2013 | EP2611458A1 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
| 07/10/2013 | EP2611449A1 Administration of lorcaserin to individuals with renal impairment |
| 07/10/2013 | EP2611441A1 Bace inhibitors for use in the treatment of diabetes |
| 07/10/2013 | CN1990473B Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof |
| 07/10/2013 | CN103201274A Pyrrolidine derivatives used as cathepsin inhibitors |
| 07/10/2013 | CN103201271A Derivatives of oxadiazole and pyridazine, their preparation and their application in therapeutics |
| 07/10/2013 | CN103201267A Ampk-activating heterocyclic compounds and methods for using the same |
| 07/10/2013 | CN103201261A Lactam derivatives useful as orexin receptor antagonists |
| 07/10/2013 | CN103200966A Double-acylated GLP-1 derivatives with a linker |
| 07/10/2013 | CN103200958A Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients |
| 07/10/2013 | CN103194489A Novel cationic liposome nucleic acid pharmaceutical preparation as well as preparation method and application thereof |
| 07/10/2013 | CN103194478A Soluble recombinant insulin, expression method of insulin derivative and application of insulin |
| 07/10/2013 | CN103194361A Pseudo-ginseng wine and preparation method thereof |
| 07/10/2013 | CN103193894A Preparation method and application of honeysuckle stem polysaccharide chromium complex |
| 07/10/2013 | CN103193881A Hypoglycemic polypeptide derivative for oral medication and use thereof |
| 07/10/2013 | CN103193878A Mutated hFGF-21 protein mature peptide and mutated hFGF-21 protein mature peptide-polyethylene glycol cross-linking agent and applications thereof |
| 07/10/2013 | CN103193860A Tanshinone compounds, preparation method and use thereof |
| 07/10/2013 | CN103193847A Pseudoginsenoside R1 and extraction method thereof, and applications of pseudoginsenoside R1 drug |
| 07/10/2013 | CN103193789A Optically active butylphthalide open-ring derivative, preparation method and medical application |
| 07/10/2013 | CN103193772A Preparation method and application of substituted aryl propionic berberine ion-pair compound |
| 07/10/2013 | CN103193742A Xanthatin derivative and medicine use thereof |
| 07/10/2013 | CN103193661A Potassium aspartate crystal, and preparation method of potassium magnesium aspartate drug composition |
| 07/10/2013 | CN103191445A Use of mesenchymal stem cell and preparation method thereof |
| 07/10/2013 | CN103191414A Fast-absorbed liquid calcium for pet and preparation method thereof |
| 07/10/2013 | CN103191367A Collateral dredging and blood pressure reducing capsules |
| 07/10/2013 | CN103191320A Soft garlic oil capsule and preparation method thereof |
| 07/10/2013 | CN103191299A Traditional Chinese medicine for treating diabetes |
| 07/10/2013 | CN103191295A Medicine for treating diabetes mellitus |
| 07/10/2013 | CN103191289A Synchronous preparation method of four effective parts in medicine pair of common anemarrhena rhizome and amur corktree bark and application thereof |
| 07/10/2013 | CN103191227A Lightyellow sophora root islet composition, and preparation method and application thereof |
| 07/10/2013 | CN103191225A Application of hedan preparation in preparation of medicine for preventing and treating lipid disorders |